Join BSMA's Community!
Please share with peers and forward this notice to whomever it is relevant. Thank you.
DATE: December 11, 2019
TIME: 10:00 am PST; 11:00 am MST; 12:00 pm CST, 1:00 pm EST
Please JOIN Thermo Fisher Scientific and BSMA to learn about critical supply chain management decisions for cell & gene therapy products on the path from clinical to commercial.
Driving Supply Chain Productivity
In Cell & Gene Therapy Clinical Trials 
A key outcome of any clinical trial is a robust data set to establish safety and efficacy, and ultimately support the launch of a commercial product. With such a focus on good data, it may be a surprise to learn that data-driven decision making is not always a focus in designing the trial, selecting vendors, and improving processes. This can have a direct on successful trial execution, and serious cost implications.

In this webinar, team members from Fisher Clinical Services , part of Thermo Fisher Scientific , will discuss key considerations in establishing and managing a successful cell therapy clinical supply chain, with an eye towards preparing for commercial launch.
In this webinar you will learn:
  • Balancing risk vs. cost in the cell therapy supply chain
  • How to set your trial up for success
  • How to improve processes and drive productivity over time
  • Case studies on how to leverage data

Join this webinar, learn what it takes to launch
your commercial product successfully
Caitlin Cumming is the Sr. Commercial Product Manager for the Bioservices team in Thermo Fisher Scientific . She currently focuses on developing new capabilities and enhancements for the Cell & Gene Therapy Supply Chain Management service line, as well as engages in key discussions with clients as they are considering the first steps in the clinical supply chain design process. Caitlin has been with Thermo Fisher for four years in a variety of product management and commercial roles, and has a background in business and global public health. 
Amy Hendricks i s a Sr. Project Manager for the Bioservices team in Thermo Fisher Scientific as well as the Cell Therapy lead for her team. She currently manages Cell and Gene therapy studies from phase 1 all the way through commercial and public health studies as a Global Project Lead or as a SME. Amy has been with Thermo Fisher for over six years as a project manager, and has a background in Epidemiology and Public Health. 
Joel Glende is the Executive Vice President, Manufacturing and Academia Member Engagement with BSMA . He is also Chair of the Transportation and Logistics Steering Committee to advance best practices in product protection, monitoring & adoption of disruptive technologies in Life Science Logistics.

Joel retired from Abbott Laboratories in 2016 after more than 38 years of service, with the last 19 years in supply chain and 15 years prior to that in packaging engineering. He has been recognized at Abbott and in the Life Sciences Industry for his leadership in leading significant efforts for the corporation in Air, Ocean and other logistics efforts resulting in mutual gain strategic partnerships across the shipper and service industry. Joel holds a Bachelor’s degree from the University of Texas, Austin.
After registering, you will receive a confirmation email containing information about joining the webinar. Also, when you receive this confirmation, there is a link to add this event to your calendar, please click on it. If you have already registered, please forward this invite to your peers, share the information with them!